Atractylenolide III Ameliorates Bile Duct Ligation-Induced Liver Fibrosis by Inhibiting the PI3K/AKT Pathway and Regulating Glutamine Metabolism

Liver fibrosis is one of the leading causes of hepatic sclerosis and hepatocellular carcinoma worldwide. However, the complex pathophysiological mechanisms of liver fibrosis are unknown, and no specific drugs are available to treat liver fibrosis. Atractylenolide III (ATL III) is a natural compound...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yan, Shi, Kun, Tu, Jiyuan, Ke, Chang, Chen, Niping, Wang, Bo, Liu, Yanju, Zhou, Zhongshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383814/
https://www.ncbi.nlm.nih.gov/pubmed/37513376
http://dx.doi.org/10.3390/molecules28145504

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383814/
https://www.ncbi.nlm.nih.gov/pubmed/37513376
http://dx.doi.org/10.3390/molecules28145504

Ejemplares similares